Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 24.99% is 74% above its 4-year average of 14.36%, near the low end of its 4-year range (4.04%–83.98%).
10.92% above its 12-month average of 22.53%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 8.19%.
OPERATING MARGIN
24.99%
OPERATING MARGIN AVG TTM
22.53%
OPERATING MARGIN AVG 3Y
12.56%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+10.92%
CURRENT VS 3Y AVG
+98.96%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
14.90%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+67.72%
vs the sector median at left
Solventum Corporation
Market Cap
$15.18B
Operating Margin
24.99%
TTM Avg
22.53%
3Y Avg
12.56%
5Y Avg
N/A
Market Cap
$14.44B
Operating Margin
39.88%
TTM Avg
32.73%
3Y Avg
24.94%
5Y Avg
21.46%
Market Cap
$16.28B
Operating Margin
20.97%
TTM Avg
21.16%
3Y Avg
19.82%
5Y Avg
19.12%
Market Cap
$13.49B
Operating Margin
12.32%
TTM Avg
13.70%
3Y Avg
16.38%
5Y Avg
21.25%
Market Cap
$13.15B
Operating Margin
12.35%
TTM Avg
9.13%
3Y Avg
12.39%
5Y Avg
13.51%
Market Cap
$12.50B
Operating Margin
-2.39%
TTM Avg
-1.31%
3Y Avg
-6.02%
5Y Avg
0.15%
Market Cap
$17.88B
Operating Margin
15.73%
TTM Avg
16.64%
3Y Avg
15.15%
5Y Avg
12.43%
Market Cap
$12.01B
Operating Margin
18.00%
TTM Avg
16.91%
3Y Avg
21.06%
5Y Avg
16.78%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $15.18B | 24.99% | 22.53% | 12.56% | N/A |
| Exelixis, Inc. (EXEL)vs › | $14.44B | 39.88% | 32.73% | 24.94% | 21.46% |
| Medpace Holdings, Inc. (MEDP)vs › | $16.28B | 20.97% | 21.16% | 19.82% | 19.12% |
| Revvity, Inc. (RVTY)vs › | $13.49B | 12.32% | 13.70% | 16.38% | 21.25% |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.15B | 12.35% | 9.13% | 12.39% | 13.51% |
| Penumbra, Inc. (PEN)vs › | $12.52B | 12.45% | 10.35% | 7.09% | 3.40% |
| Baxter International Inc. (BAX)vs › | $12.50B | -2.39% | -1.31% | -6.02% | 0.15% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $17.88B | 15.73% | 16.64% | 15.15% | 12.43% |
| Encompass Health Corporation (EHC)vs › | $12.01B | 18.00% | 16.91% | 21.06% | 16.78% |
| DaVita Inc. (DVA)vs › | $11.64B | 15.06% | 15.52% | 13.94% | 14.32% |
Gross Margin
54.7%
Operating Margin
25.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 8.19% |
| 2026-03-31 | 4.04% |
| 2025-12-31 | 83.98% |
| 2025-09-30 | 6.54% |
| 2025-06-30 | 9.90% |
| 2025-03-31 | 7.34% |
| 2024-12-31 | 6.55% |
| 2024-09-30 | 13.21% |
| 2024-06-30 | 11.73% |
| 2024-03-31 | 18.90% |
| 2023-12-31 | 19.94% |
| 2023-09-30 | 24.30% |
| 2023-06-30 | 20.09% |
| 2023-03-31 | 18.15% |
| 2022-12-31 | 11.17% |
| 2022-09-30 | 21.06% |
| 2022-06-30 | 21.50% |
| 2022-03-31 | 21.50% |
